Caralin Schneider
Internal Medicine · Miami, FLNPI 1174104061
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,433, 2.1 times the $687 reported in 2023.
Across 67 payments — averaging $48.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$710
- Sanofi$548
- Novartis$314
- Lilly USA, LLC$294
- Janssen Scientific Affairs, LLC$286
- Johnson & Johnson$221
- plus $861 from 14 others
What the payments were for
- Food & beverage$3,13497%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $710 |
| Sanofi | 9 | $548 |
| Novartis | 12 | $314 |
| Lilly USA, LLC | 4 | $294 |
| Janssen Scientific Affairs, LLC | 2 | $286 |
| Johnson & Johnson | 6 | $221 |
| Dermavant Sciences, Inc. | 1 | $159 |
| Arcutis Biotherapeutics, Inc. | 4 | $143 |
| Incyte Corporation | 1 | $131 |
| UCB, Inc. | 2 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| E.r. Squibb & Sons, L.L.C. | 1 | $60 |
| Boehringer Ingelheim | 2 | $53 |
| Pfizer | 2 | $44 |
| Amgen | 2 | $31 |
| Galderma Laboratories, L.p. | 1 | $26 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,234 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Moxifloxacin Hcl | 11 | $197 |
| Ketoconazole | 16 | $164 |
| Rifampin | 21 | $109 |
| Minocycline Hcl | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Miami
- Haytham ElgammalMiami$2.2M
- Richard AguilarMiami$239K
- Maria Delgado LelievreMiami$80K
- Marlow HernandezMiami$58K
- Steven CohnMiami$47K
- Joseph PiperatoMiami$45K
- Simon AbelsonMiami$44K
- Joel Brooks TamayoMiami$42K
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.